PBM reform isn’t expected to ride along with the next government funding packages, which could push any prospect of legislative reform closer to 2025. Meanwhile FTC says it is facing difficulty getting all the information for its investigation.
Disagreement among Senate and House Republicans over whether to tackle commercial health plans in pharmacy benefits manager reform ultimately led the topic to be taken off the table as a ride-along measure for one of the upcoming government funding bills.
The US government is currently operating under two continuing resolutions which fund different government departments. One of those CRs expires on 1 March and the other expires on 8 March
A new ordinance for addressing drug shortages in Austria requires drug companies distributing any of the hundreds of products listed in an accompanying annex to maintain adequate stock in the country to meet patient demand for four months.
The European Medicines Agency has for the first time explicitly stated it is considering the use of large language models as a tool to improve the readability of a scientific guideline.
England’s health technology assessment institute, NICE, must ensure that there is clarity for manufacturers on how its methods and processes might change following testing in its sandbox environment, the Association of the British Pharmaceutical Industry said.
